Due to COVID-19 we are now offering TeleHealth Office Visits via video or phone call. Learn More >
We have prepared for the Coronavirus (COVID-19). We have updated policies to protect our patients and staff. Learn more.

Informational Articles

  • Incidence and Treatment of Colorectal Cancer
    Colorectal cancer is the second most rampant cancer in women, the third most common for men, and the third most widespread cancer in the world. Risk factors for colorectal cancer include consumption of processed meat, sedentary life, low consumption of fiber or calcium, excess body weight, aging, smoking, and consumption of alcohol. Colorectal cancer is […]
  • Non-Smokers are Likely to Respond Differently to Lung Cancer Treatment
      The Institute of Cancer Research (ICR) reports that lung cancer in non-smokers and smokers varies, and it responds differently to various forms of treatment. The research conducted in Taiwan shows that tumors among non-smokers had genetic changes that varied depending on the patient’s age or sex. Many lung cancer patients (non-smokers) had signs of […]
  • When Metastatic Lung Cancer Patients Should Stop Using Immunotherapy
    Metastatic lung cancer patients should continue with immunotherapy for up to 2 years if they are responsive and are not experiencing excessive toxicity or disease progression. Initially, stage III lung cancer patients usually undergo immunotherapy for one year as established in one clinical trial. The trial results showed that durvalumab (imfinzi) could prolong overall survival […]
  • New Guidelines for Patients to Access Cancer Care during Covid-19
    The Federal guidelines have allowed cancer patients to access care even with the ongoing coronavirus epidemic. Since the outbreak of Covid-19, cancer care teams and their patients have experienced difficulty in making choices about administering treatments, screening, and diagnostic care. The guidelines provided earlier advised some care centers to postpone non-essential and elective procedures to […]
  • Cancer Care Management during the Coronavirus Era
    Most cancer treatments and clinical trials have either been put on hold or postponed during the COVID 19 pandemic. This is because both newly diagnosed and metastatic disease patients are afraid of getting infected. Right now, COVID-19 has become the leading cause of death globally, overshadowing Ischemic heart disease and cancer. This is due to […]

More Choice Cancer Care Centers